The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
INDUCE-1: A phase I open-label study of GSK3359609, an ICOS agonist antibody, administered alone and in combination with pembrolizumab in patients with advanced solid tumors.
 
ERIC ANGEVIN
Consulting or Advisory Role - GlaxoSmithKline; MSD
Research Funding - Abbvie; Roche; Sanofi
 
Mary S. Barnette
Employment - GlaxoSmithKline
Stock and Other Ownership Interests - GlaxoSmithKline
 
Todd Michael Bauer
Employment - Sarah Cannon Research Institute; Tennessee Oncology
Research Funding - Abbvie (Inst); AstraZeneca (Inst); Calithera Biosciences (Inst); Daiichi Sankyo (Inst); Deciphera (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Ignyta (Inst); Immunogen (Inst); Incyte (Inst); Kolltan Pharmaceuticals (Inst); Leap Therapeutics (Inst); Lilly (Inst); MabVax (Inst); MedImmune (Inst); medpacto (Inst); Merck (Inst); Merrimack (Inst); Millennium (Inst); Mirati Therapeutics (Inst); Novartis (Inst); Pfizer (Inst); Principa Biopharma (Inst); Stemline Therapeutics (Inst)
 
Daniel C. Cho
Honoraria - Bristol-Myers Squibb; Exelixis; Genentech
Consulting or Advisory Role - Pfizer; Prometheus
 
Catherine Elizabeth Ellis
Employment - GlaxoSmithKline
Stock and Other Ownership Interests - GlaxoSmithKline
 
Hui Kong Gan
Consulting or Advisory Role - AbbVie; Merck Serono
Speakers' Bureau - Abbvie; Bristol-Myers Squibb; Ignyta
Research Funding - AbbVie
Travel, Accommodations, Expenses - AbbVie; Ignyta; Merck Sharp & Dohme
 
Aaron Richard Hansen
No Relationships to Disclose
 
Axel Hoos
Employment - GlaxoSmithKline
Leadership - Imugene
Stock and Other Ownership Interests - GlaxoSmithKline; Imugene
 
Roxanne C Jewell
Employment - GlaxoSmithKline; Novartis
Stock and Other Ownership Interests - GlaxoSmithKline; Novartis
 
Jessica Katz
Employment - Bristol-Myers Squibb; GlaxoSmithKline
Stock and Other Ownership Interests - Bristol-Myers Squibb; GlaxoSmithKline
 
Juan Martin-Liberal
No Relationships to Disclose
 
Michele Maio
Honoraria - AstraZeneca; Bristol-Myers Squibb; GlaxoSmithKline; MSD; Roche
Consulting or Advisory Role - Incyte
Research Funding - AstraZeneca; Bristol-Myers Squibb
 
Patrick A. Mayes
Employment - GlaxoSmithKline
Stock and Other Ownership Interests - GlaxoSmithKline
Patents, Royalties, Other Intellectual Property - GlaxoSmithKline
 
Michael Millward
Consulting or Advisory Role - Bristol-Myers Squibb
 
Victor Moreno
No Relationships to Disclose
 
Anthony J. Olszanski
Consulting or Advisory Role - Bristol-Myers Squibb; G1 Therapeutics; Kyowa Hakko Kirin; Merck; Takeda
Research Funding - Advaxis (Inst); Amgen (Inst); Bristol-Myers Squibb (Inst); EMD Serono (Inst); Ignyta (Inst); Immunocore (Inst); Incyte (Inst); Kura Oncology (Inst); Kyowa Hakko Kirin (Inst); Lilly (Inst); Mirati Therapeutics (Inst); Novartis (Inst); Pfizer (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Churchill Pharmaceuticals; G1 Therapeutics; Kyowa Hakko Kirin; Takeda
 
Danny Rischin
Research Funding - Genentech/Roche; Merck; Threshold Pharmaceuticals
 
Jan H. M. Schellens
No Relationships to Disclose
 
Sapna Yadavilli
Employment - GlaxoSmithKline
Stock and Other Ownership Interests - GlaxoSmithKline
 
Helen Zhou
Employment - Bristol-Myers Squibb; GlaxoSmithKline
Stock and Other Ownership Interests - Bristol-Myers Squibb; GlaxoSmithKline